0
Breakthrough chikungunya single-dose vaccine success in Phase III trials
Phase III trials for the VLA1553 vaccine against chikungunya virus indicated promising results by inducing protective CHIKV neutralizing antibody titers…
Browsing: Emerging Disease > Chikungunya
0
US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines
Take a look at this month’s industry headlines including FDA warnings over hepatitis C drugs in patients with liver injury, a new infectious diseases strategy for the UK and priority review for Merck’s Ebola vaccine.
0
Funding received for first Phase III trial of a chikungunya vaccine: June’s industry headlines
Take a look at this month’s industry headlines including an FDA approval for Zebraxa, new funding for chikungunya vaccine clinical…
0
Vector-borne disease: an increasing problem for the United States
A CDC report has shown that infection rates of diseases transmitted via the bite of an infected mosquito, tick or flea have tripled in the United States since the year 2004.
0
US Olympians at Rio 2016 were not infected with Zika
Blood samples from US athletes and staff who travelled to Rio de Janeiro, Brazil, for the 2016 Summer Games were not infected with Zika virus but tested positive for other viral infections, including West Nile Virus, dengue and chikungunya.
0
WHO reports chikungunya outbreak in Italy
As of September 14th, fourteen confirmed cases of chikungunya have been reported in Italy, specifically in Rome and the coastal area of the Lazio Region.
0
Chikungunya vaccine to enter Phase II trials in endemic areas
A chikungunya vaccine, developed by Themis Bioscience GmbH will be assessed for safety and efficacy in Phase II trials in Puerto Rico from August 2017.
0
Harnessing citizen science to tackle mosquito-borne diseases
Human mobility and globalization have brought new invasive species to other countries. In terms of environment and nature, some of…
0
Could severe complications from Zika infection be more common than previously thought?
Researchers have analyzed the clinical characteristics of Zika infection in Canadian travelers returning from the Americas, discovering that severe complications might be more common than previously estimated.
0
New study elucidates a key infection mechanism for chikungunya virus
Researchers have identified a crucial mechanism by which the chikungunya virus infects host cells and mediates disease severity. This could present a future treatment target for both chikungunya and related viruses.